Comprehensive Thyroid & Lung

The Archer® FusionPlex Comprehensive Thyroid and Lung (CTL) panel is a targeted next-generation sequencing (NGS) panel to detect gene fusions, single-nucleotide variant (SNV), indels, splicing and gene expression in 36 genes associated with lung and thyroid cancers. This panel complements the Archer VariantPlex® CTL panel for comprehensive mutation profiling of fusions, copy number variations (CNVs) and variants.
Key Features
Comprehensive fusion detection

Detect known and novel fusions in lung and thyroid cancers.

Confirm fusion events

Expression imbalance is detected from molecular barcodes for fusion confirmation.

Detect splice variants

Identify expressed EGFRvIII and MET exon 14 skipping events.

Expression profiling

Molecular barcodes enable expression profiling of relevant targets.

Streamlined, lyophilized workflow

Minimize hands-on time and replication error.

Specifications and Performance


Gene Targets

> 10ng

Input Nucleic Acid Required*

> 93%

Unique Molecular On-Target %

2.5 hours

Hands-on Time

9 hours

Total Time

Illumina and
Ion Torrent


Fresh Frozen or FFPE

Sample Types

*Input recommendations for FFPE samples vary depending on Archer PreSeq® RNA QC score; 50ng input recommended in absence of PreSeq screening

Gene Targets


Fusion, splicing or exon-skipping

NeeD to Modify Your Panel?

Add any of our wet lab-validated designs to this panel with Archer Assay Designer to build an assay that fits your exact requirements.

  • Find Your Fit

This website stores cookies on your computer. These cookies are used to improve your website and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy.

We won’t track your information when you visit our site. But in order to comply with your preferences, we’ll have to use just one tiny cookie so that you’re not asked to make this choice again.